Prulifloxacin + Placebo
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Acute Gastroenteritis in Adult Travelers
Conditions
Acute Gastroenteritis in Adult Travelers
Trial Timeline
Aug 1, 2006 → Mar 1, 2008
NCT ID
NCT00392574About Prulifloxacin + Placebo
Prulifloxacin + Placebo is a phase 3 stage product being developed by Merck for Acute Gastroenteritis in Adult Travelers. The current trial status is completed. This product is registered under clinical trial identifier NCT00392574. Target conditions include Acute Gastroenteritis in Adult Travelers.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00392574 | Phase 3 | Completed |
Competing Products
20 competing products in Acute Gastroenteritis in Adult Travelers